wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35619065-4C9E6EB7-F947-4837-A2A9-045AFC1F684C
Q35619065-4C9E6EB7-F947-4837-A2A9-045AFC1F684C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35619065-4C9E6EB7-F947-4837-A2A9-045AFC1F684C
The power of phase II end-points for different possible mechanisms of action of an experimental treatment
P2860
Q35619065-4C9E6EB7-F947-4837-A2A9-045AFC1F684C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35619065-4C9E6EB7-F947-4837-A2A9-045AFC1F684C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0db7b16c1465c18006d9d638f3c22dfd09ae2617
P2860
Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.